DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1

Information source: National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Amphetamine-Related Disorders

Intervention: Bupropion (Drug)

Phase: Phase 1

Status: Active, not recruiting

Sponsored by: National Institute on Drug Abuse (NIDA)

Official(s) and/or principal investigator(s):
Thomas Newton, M.D., Principal Investigator, Affiliation: National Institute on Drug Abuse (NIDA)

Summary

The purpose of this study is to assess potential interactions between intravenous (IV) methamphetamine and oral bupropion.

Clinical Details

Official title: Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between IV Methamphetamine and Oral Bupropion

Study design: Allocation: Randomized, Masking: Double-Blind, Primary Purpose: Diagnostic

Primary outcome:

Psychological effects

BP, HR

Detailed description: This is a human laboratory clinical pharmacology study to assess potential interactions between IV methamphetamine challenge and treatment with oral sustained-release bupropion.

Eligibility

Minimum age: 18 Years. Maximum age: 45 Years. Gender(s): Both.

Criteria:

Inclusion Criteria: Please contact site director for more details. Exclusion Criteria: Please contact site director for more details.

Locations and Contacts

UCLA Integrated Substance Abuse Program, Los Angeles, California 90024, United States

University of Texas Health Science Center, Houston, Texas 77225, United States

Additional Information

Starting date: June 2002
Last updated: February 8, 2007

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017